Zinc trial aims to boost immunity in HIV patients who Don't respond to standard drugs

NCT ID NCT06612554

Recruiting now Disease control Sponsor: Parc de Salut Mar Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether high-dose zinc supplements can improve immune function in people with HIV who still have low CD4 counts despite successful antiretroviral therapy. 120 participants will receive either zinc or a placebo for 16 weeks. Researchers will measure changes in CD4 counts, inflammation, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: zinc acetate (dietary supplement)
What this could lead to: If it works, this could offer a simple, cheap way to improve immune function and reduce inflammation in HIV patients who don't respond well to standard therapy.
What could go wrong: This is a small, early-phase trial (120 people) testing a high dose of zinc. Previous studies have shown mixed results, and the supplement may not work or could cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease Inflammation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV HIV INFECTION ZINC STATUS

Contacts and locations

Locations

Hospital del Mar
RECRUITING

Barcelona, 08003, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.